MiniMed 670G System
Medtronic MiniMed, Inc. · Decision date Oct 2, 2025
What did the FDA approve?
FDA records P160017/S129 as a supplement to PMA P160017, with the supplement type “Special (Immediate Track)”. The recorded decision is approval, dated Oct 2, 2025.
FDA approval order statement
Approval for changes to the labeling to include formatting changes and new warnings for battery depletion, delivery volume accuracy during air travel, and pump to infusion set distance.
- Regulatory pathway
- PMA supplement
- Supplement type
- Special (Immediate Track)
- Clinical specialty
- Clinical Chemistry
- Decision date
- Oct 2, 2025
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
Regulatory record facts
- Identifier
- P160017/S129
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic MiniMed, Inc.
- Product code
- OZP
- Decision code
- APPR
- Decision date
- Oct 2, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated insulin dosing device system, single hormonal control.
- Applicant
- Medtronic MiniMed, Inc.
- Product code
- OZP
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P160017. Subsequent supplements may change the device or its indications.
FDA decision timeline
P160017 · Original PMA
MiniMed 670G System
P160017/S122 · Related supplement
MiniMed 770G System
P160017/S126 · Related supplement
MiniMed 670G System
P160017/S124 · Related supplement
MiniMed 780G System
P160017/S129 received
Application receipt date recorded by FDA.
P160017/S128 · Related supplement
MiniMed 780G System
P160017/S129 · FDA decision
Special (Immediate Track)
P160017/S127 · Related supplement
MiniMed 780G System
P160017/S130 · Related supplement
MiniMed 670G System; MiniMed 770G System; MiniMed 780G System
P160017/S132 · Related supplement
MiniMed 780G System
P160017/S134 · Related supplement
MiniMed 780G System
P160017/S131 · Related supplement
MiniMed 670G system MiniMed 770G system MiniMed 780G system
P160017/S125 · Related supplement
MiniMed 780G System
P160017/S133 · Related supplement
MiniMed 670G System
P160017/S136 · Related supplement
Simplera Sync Sensor
P160017/S137 · Related supplement
Simplera and Simplera Sync
P160017/S135 · Related supplement
MiniMed 780G System
P160017/S138 · Related supplement
Simplera Sync; Guardian Sensor (3) Transfer to MPROC; MiniMed 780G System with G4S
P160017/S139 · Related supplement
MiniMed 770G Insulin Pump; MiniMed 780G Insulin Pump
P160017/S140 · Related supplement
MiniMed 780G System
Timeline entries are records held by MedtechLedger for P160017. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160017
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic MiniMed, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 18000 Devonshire St., Northridge, CA, 91325
Sources and methodology
- Original FDA record: P160017/S129
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






